New targets for therapy in acute myeloid leukemia

This publication has 27 references indexed in Scilit:

• Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML
  Leukemia, 2002
• HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
  Leukemia, 2002
• FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model
  Blood, 2002
• Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse
  Journal of Clinical Oncology, 2001
• FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia
  Blood, 2001
• The Growth Suppressor PML Represses Transcription by Functionally and Physically Interacting with Histone Deacetylases
  Molecular and Cellular Biology, 2001
• Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
  Nature Medicine, 2000
• c‐kit proto‐oncogene exon 8 in‐frame deletion plus insertion mutations in acute myeloid leukaemia
  British Journal of Haematology, 1999
• Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines
  Leukemia, 1997
• FMS mutations in myelodysplastic, leukemic, and normal subjects.
  Proceedings of the National Academy of Sciences, 1990